Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Your RPS

Luigi G Martini takes up post as RPS chief scientist

Luigi G Martini FRPharmS has been confirmed as the Royal Pharmaceutical Society’s new chief pharmaceutical scientist, calling it a “privilege and an honour”

Luigi G Martini

Source: MAG / The Pharmaceutical Journal

Martini, the new RPS chief scientist, has gained experience across multiple sectors of pharmacy

Luigi G Martini FRPharmS has been confirmed as the Royal Pharmaceutical Society’s (RPS) new chief pharmaceutical scientist. He joins Claire Thompson, deputy chief scientist, and Colin Cable, assistant chief scientist.

Martini and his team will provide scientific expertise to the three national pharmacy boards, and to the Society’s Expert Advisory Boards. He will also contribute to the Society’s public engagement agenda.

Martini, known usually as Gino, first practised as a community pharmacist before completing a PhD in drug delivery from the University of Manchester. He then moved to a career in the pharmaceutical industry, and has gained experience at GlaxoSmithKline Pharmaceuticals, Roche Products Ltd and Shire Pharmaceuticals in a range of commercial, innovation and medical affairs roles. Martini is also a visiting professor in pharmaceutical innovation at King’s College London. 

Describing his appointment as a “privilege and an honour”, Martini said “I have always been proud to call myself a pharmacist and to call myself a member of the Royal Pharmaceutical Society.

This appointment is a clear signal that the RPS is determined to ensure that science into practice is a core tenet within the profession.”

Members who would like to share their views on how the RPS’s science and research agenda should develop can contact Martini at science@rpharms.com.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204128

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Luigi G Martini

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.